BLEPHAMIDE is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Sulfacetamide Sodium; Prednisolone Acetate.
| Product ID | 0023-0313_376f9d35-04d0-4089-b303-99c0d7671ae7 |
| NDC | 0023-0313 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BLEPHAMIDE |
| Generic Name | Sulfacetamide Sodium And Prednisolone Acetate |
| Dosage Form | Ointment |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1987-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA087748 |
| Labeler Name | Allergan, Inc. |
| Substance Name | SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE |
| Active Ingredient Strength | 100 mg/g; mg/g |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Sulfonamide Antibacterial [EPC],Sulfonamides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1987-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA087748 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 1987-01-01 |
| Ingredient | Strength |
|---|---|
| SULFACETAMIDE SODIUM | 100 mg/g |
| SPL SET ID: | c68ebddc-dcb5-4695-a66b-d03a65a110f6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-0313 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
| 11980-022 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BLEPHAMIDE 72119340 0724725 Live/Registered |
Allergan Pharmaceuticals, Inc. 1961-05-05 |